Docking and Molecular Dynamics Simulation of Carbonic Anhydrase II Inhibitors from Phenolic and Flavonoid Group

被引:9
作者
Aditama, Reza [1 ]
Mujahidin, Didin [1 ]
Syah, Yana Maolana [1 ]
Hertadi, Rukman [1 ]
机构
[1] Bandung Inst Technol, Dept Chem, Jalan Ganeca 10, Bandung 40132, Indonesia
来源
INTERNATIONAL SYMPOSIUM ON APPLIED CHEMISTRY 2015 | 2015年 / 16卷
关键词
docking; flavonoid; carbonic anhydrase inhibitor; molecular dynamics simulation;
D O I
10.1016/j.proche.2015.12.064
中图分类号
O69 [应用化学];
学科分类号
070301 [无机化学];
摘要
Carbonic Anhydrase II (CAII) has role in pH regulation, water transport and hydration of CO2. In addition, CAII is also related to many diseases, including glaucoma, tumours, epilepsy, diabetes and osteopetrosis. Various inhibitors for CAII have been developed and commercialized as a drug. Recent development of CAII inhibitors drive the invention of novel inhibitors based on natural product structures and their derivatives. This research aim to screen potential inhibitors from phenolic and flavonoid groups by in silico approach. The screening of natural products compounds was performed by a molecular docking method. The best ligand derived from the molecular docking selection was further refined with a molecular dynamics simulation and the resulted structure was used to evaluate the stability of CAII-ligand complex. By using the upper mentioned procedures, fisetin (Fic) and 6-(3,4-dihydroxypheny1)-5,6,7,8-tetrahydronaphthalene-1,3,7-triol (Afr3) were strongly suggested to be a potent inhibitor for CAII. (C) 2015 The Authors. Published by Elsevier B.V.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 14 条
[1]
Combining docking and molecular dynamic simulations in drug design [J].
Alonso, Hernan ;
Bliznyuk, Andrey A. ;
Gready, Jill E. .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (05) :531-568
[2]
Case DA., 2014, AMBER14
[3]
VMD: Visual molecular dynamics [J].
Humphrey, W ;
Dalke, A ;
Schulten, K .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1996, 14 (01) :33-38
[4]
Screening and docking studies of natural phenolic inhibitors of carbonic anhydrase II [J].
HuoQiang, Huang ;
Pan XuLin ;
Ji ChangJiu ;
Zeng GuangZhi ;
Jiang LiHua ;
Fu Xiang ;
Liu JiKai ;
Hao XiaoJiang ;
Zhang YingJun ;
Tan NingHua .
SCIENCE IN CHINA SERIES B-CHEMISTRY, 2009, 52 (03) :332-337
[5]
CARBONIC ANHYDRASE - CHEMISTRY PHYSIOLOGY AND INHIBITION [J].
MAREN, TH .
PHYSIOLOGICAL REVIEWS, 1967, 47 (04) :595-+
[6]
Structural Survey of Zinc-Containing Proteins and Development of the Zinc AMBER Force Field (ZAFF) [J].
Peters, Martin B. ;
Yang, Yue ;
Wang, Bing ;
Fuesti-Molnar, Laszlo ;
Weaver, Michael N. ;
Merz, Kenneth M., Jr. .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2010, 6 (09) :2935-2947
[7]
Inhibition of carbonic anhydrase isozymes I and II with natural products extracted from plants, mushrooms and honey [J].
Sahin, Huseyin ;
Can, Zehra ;
Yildiz, Oktay ;
Kolayli, Sevgi ;
Innocenti, Alessio ;
Scozzafava, Gabriele ;
Supuran, Claudiu T. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (03) :395-402
[8]
HUMAN CARBONIC-ANHYDRASES AND CARBONIC-ANHYDRASE DEFICIENCIES [J].
SLY, WS ;
HU, PY .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :375-401
[9]
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors [J].
Sugrue, MF .
PROGRESS IN RETINAL AND EYE RESEARCH, 2000, 19 (01) :87-112
[10]
Carbonic anhydrase inhibitors and their therapeutic potential [J].
Supuran, CT ;
Scozzafava, A .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (05) :575-600